2.

CDO1甲基化水平与临床病理特征的关系

The relationship between CDO1 methylation level and clinicopathological characteristics

Factor	CDO1 relative expression (25%, 75%)	P
a: Because the number of the patients with other pathological types was fewer, the related test was not done.
All the subjects (n=351)
Gender		0.35
Male	0.028 (0.013, 0.440)
Female	0.032 (0.017, 0.300)
Age (yr)		0.004
> 60	0.120 (0.014, 1.630)
≤60	0.029 (0.015, 0.083)
Types of diseases		< 0.001
Malignant tumor	0.092 (0.016, 1.830)
Benign lung disease	0.018 (0.011, 0.058)
Health control	0.028 (0.017, 0.050)
Smoking history		0.733
Ever	0.029 (0.013, 1.506)
Never	0.030 (0.016, 0.230)
Malignant tumor (n=178)
Metastasis		< 0.001
None	0.028 (0.013, 0.230)
Yes	0.680 (0.027, 7.610)
TNM stage		< 0.001
Ⅰ	0.0280 (0.013, 0.230)
Ⅱ	0.037 (0.016, 2.910)
Ⅲ	0.054 (0.014, 2.760)
Ⅳ	2.350 (0.150, 12.840)
Histologya		0.08
AD	0.058 (0.014, 0.77)
SCC	0.160 (0.018, 6.210)
SCLC	2.100 (0.012, 24.940)